Exhibit 10.10
FORM OF EXPENSE REIMBURSEMENT AGREEMENT
This Expense Reimbursement Agreement (the “Agreement”) is made this _____ day of _____, 2022, by and between Varagon Capital Corporation, a Maryland corporation (the “Company”), and VCC Advisors, LLC, a Delaware limited liability company (the “Adviser”).
WHEREAS, the Company is a non-diversified, closed-end management investment company that intends to elect to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”);
WHEREAS, the Company has retained the Adviser to furnish investment advisory services to the Company on the terms and conditions set forth in the investment advisory agreement, dated _________, 2022, entered between the Company and the Adviser, as may be amended or restated (the “Advisory Agreement”);
WHEREAS, the Company and the Adviser have determined that it is appropriate and in the best interests of the Company that the Adviser fund all of the Organizational and Offering Expenses (as defined in Section 1of this Agreement)) incurred by the Company and that the Company will be obligated to reimburse to the Adviser at a later date as set forth herein.
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the parties hereby agree as follows:
1. Adviser Expense Payments for the Company
The Adviser, or its affiliates, will fund all of the Organizational and Offering Expenses incurred by the Company (each such payment, an “Expense Payment”). “Organizational and Offering Expenses” means all costs and expenses (whether incurred before, on or after the date of the Company’s preliminary private placement memorandum) pertaining to the organization and establishment of the Company (including any subsidiaries of the Company and the transactions contemplated by the merger of Varagon Fund I, L.P. with and into the Company and the acquisition of a portfolio of existing loans), including, without limitation, any related third-party legal, tax and accounting advisory fees and expenses, capital raising expenses (including printing expenses and other similar costs, fees and expenses, and regulatory, compliance, and administrative filings) and other organizational and offering expenses, but excluding the fees of the placement agent (or any successor placement agent).
2. Reimbursement of Expense Payments by the Company
(a) To ensure that each investor that enters into a subscription agreement with the Company during the Fundraising Period (as defined below) shares equitably in the Organizational and Offering Expenses, during the first four fiscal quarters following the Fundraising Period, the Company shall reimburse the Adviser, or its affiliates, as applicable, for the Organizational and Offering Expenses incurred by the Company and funded by the Adviser or its affiliates. Any reimbursement payments required to be made by the Company pursuant to this Section 2(a) of this Agreement shall be referred to herein as a “Reimbursement Payment.”
(b) The “Initial Closing” will occur on the first date an investor’s subscription agreement relating to the Company’s common stock is accepted by the Company. The Company expects to hold additional closings, from time to time, in the Adviser’s sole discretion, for a period of 24 months after the Initial Closing (the “Fundraising Period”). The Fundraising Period may be extended by up to an additional 18 months in the sole discretion of the Company’s board of directors (i.e., from 24 months to up to 42 months after the Initial Closing).
(c) For the avoidance of doubt, to the extent the Fundraising Period is extended by up to an additional 18 months in the sole discretion of the Company’s board of directors (as described in Section 2(b) of this Agreement), the Company shall reimburse the Adviser, or, as applicable, its affiliates, for the Organizational and Offering Expenses incurred by the Company during the first four fiscal quarters following the extended Fundraising Period.
(d) The Company’s obligation to make a Reimbursement Payment will automatically become a liability of the Company on the date on which the Company elects to be regulated as a business development company under the 1940 Act. For the avoidance of doubt, this is not conditioned on any performance threshold and is not considered a contingent liability for accounting purposes.